ChiCTR2600125629 版本V1.0 版本创建时间2026/05/28 17:57:50 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600125629 

最近更新日期:

Date of Last Refreshed on:

2026-05-28 17:57:29 

注册时间:

Date of Registration:

2026-05-28 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肱肌平面阻滞和腋路臂丛阻滞在桡骨远端骨折患者术后镇痛效果的比较研究

Public title:

A comparative study of the postoperative analgesic effects of brachial plexus block at the humeral muscular plane and axillary approach in patients with distal radius fractures

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肱肌平面阻滞和腋路臂丛阻滞在桡骨远端骨折患者术后镇痛效果的比较研究

Scientific title:

A comparative study of the postoperative analgesic effects of brachial plexus block at the humeral muscular plane and axillary approach in patients with distal radius fractures

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

谷紫嫣 

研究负责人:

谷紫嫣 

Applicant:

Gu Ziyan 

Study leader:

Gu Ziyan 

申请注册联系人电话:

Applicant telephone:

+86 130 5627 6117

研究负责人电话:

Study leader's
telephone:

+86 130 5627 6117

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

guziyan0410@163.com

研究负责人电子邮件:

Study leader's E-mail:

guziyan0410@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宜山路600号

研究负责人通讯地址:

上海市徐汇区宜山路600号

Applicant address:

600 Yishan Road, Xuhui District, Shanghai

Study leader's address:

600 Yishan Road, Xuhui District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市第六人民医院

Applicant's institution:

Shanghai Sixth People's Hospital

研究负责人所在单位:

上海市第六人民医院

Affiliation of the Leader:

Shanghai Sixth People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-224-(1)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市第六人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Sixth People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-01-26 00:00:00

伦理委员会联系人:

贾伟平

Contact Name of the ethic committee:

Jia Weiping

伦理委员会联系地址:

上海市徐汇区宜山路600号

Contact Address of the ethic committee:

600 Yishan Road, Xuhui District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 6436 9181

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市第六人民医院

Primary sponsor:

Shanghai Sixth People's Hospital

研究实施负责(组长)单位地址:

上海市徐汇区宜山路600号

Primary sponsor's address:

600 Yishan Road, Xuhui District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

上海

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海第六人民医院

具体地址:

上海市徐汇区宜山路600号

Institution
hospital:

Shanghai Sixth People's Hospital

Address:

600 Yishan Road, Xuhui District, Shanghai

经费或物资来源:

上海市第六人民医院院级课题(ynts202305)

Source(s) of funding:

Hospital-level project of Shanghai Sixth People's Hospital(ynts202305)

研究疾病:

不适用  

Target disease:

Not applicable

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

比较肱肌平面阻滞和腋路臂丛神经阻滞对桡骨远端骨折手术患者术后的镇痛效果,以及比较术后患者肩、肘关节和小指的肌肉活动度  

Objectives of Study:

Compare the postoperative analgesic effects of the brachial plane block and axillary brachial plexus block in patients undergoing distal radial fracture surgery, and compare the postoperative muscle activity of the shoulder, elbow, and little finger in patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 18岁-60岁患者, 2.ASA I-III级, 3.拟行单侧桡骨远端骨折手术喉罩全麻手术。

Inclusion criteria

1. Patients aged 18-60 years, 2. ASA I-III, 3. Scheduled for unilateral distal radius fracture surgery under laryngeal mask general anesthesia.

排除标准:

1.穿刺部位感染。 2.前臂手术史。 3.已有上肢神经损伤。 4.局部麻醉禁忌症。 5.局部麻醉药过敏史。 6.凝血功能障碍。 7.药物或酒精滥用。 8.每日服用止痛药。 9.合并其他部位外伤。 10.术前谵妄、帕金森病、痴呆症、严重神经系统疾病、3个月内卒中、重度肝功能不全(Child-Pugh C级)、肾功能衰竭。

Exclusion criteria:

1. Infection at the puncture site. 2. History of forearm surgery. 3. Existing upper limb nerve injury. 4. Contraindications to local anesthesia. 5. History of allergy to local anesthetics. 6. Coagulation disorders. 7. Drug or alcohol abuse. 8. Daily use of painkillers. 9. Combined trauma to other sites. 10. Preoperative delirium, Parkinson's disease, dementia, severe neurological disorders, stroke within the past 3 months, severe liver dysfunction (Child-Pugh class C), renal failure.

研究实施时间:

Study execute time:

From 2025-10-08 00:00:00 To 2027-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-01 00:00:00 To 2027-06-30 00:00:00

干预措施:

Interventions:

组别:

肱肌平面阻滞组

样本量:

55

Group:

Brachial Plane Block Group

Sample size:

干预措施:

术前30min,抽取局麻药0.5%罗哌卡因25ml,在肘横纹上方寻找三股神经正中神经(MN),桡神经(RN)和前臂外侧皮神经(LCNF),在肱肌表面筋膜推注25ml 0.5%浓度的罗哌卡因进行神经阻滞。

干预措施代码:

Intervention:

Thirty minutes before surgery, 25 ml of 0.5% ropivacaine was drawn for local anesthesia. Above the elbow crease, the three nerves—the median nerve (MN), radial nerve (RN), and lateral cutaneous nerve of the forearm (LCNF)—were located. Then, 25 ml of 0.5% ropivacaine was injected on the fascia surface of the biceps muscle for nerve block.

Intervention code:

组别:

臂丛腋路阻滞组

样本量:

55

Group:

Brachial Plexus Axillary Block Group

Sample size:

干预措施:

术前30min,抽取局麻药0.5%罗哌卡因25ml,在腋窝寻找腋动脉外侧的正中神经(MN),腋动脉内侧下方的桡神经(RN)、内侧浅筋膜下的尺神经(ulnar nerve,UN)和肱二头肌和喙肱肌之间,呈三角形或菱形筛网状的肌皮神经,分别推注约 0.5% 6ml罗哌卡因进行神经阻滞。

干预措施代码:

Intervention:

30 minutes before surgery, 25 ml of 0.5% ropivacaine was drawn for local anesthesia. The median nerve (MN) was located lateral to the axillary artery in the armpit, the radial nerve (RN) was located below the medial side of the axillary artery, the ulnar nerve (UN) was located under the medial superficial fascia, and the musculocutaneous nerve, forming a triangular or diamond-shaped mesh between the biceps brachii and coracobrachialis muscles. About 6 ml of 0.5% ropivacaine was injected to block each nerve.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

上海 

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海市第六人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Sixth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后24小时动态疼痛强度

指标类型:

主要指标

Outcome:

Postoperative 24-hour dynamic pain intensity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者的静息痛

指标类型:

次要指标

Outcome:

Resting pain of the patient

Type:

Secondary indicator

测量时间点:

术前1h,术后1h,术后6h,次日九点,术后24h

测量方法:

Measure time point of outcome:

1 hour before surgery, 1 hour after surgery, 6 hours after surgery, 9 o'clock the next day, and 24 hours after surgery

Measure method:

指标中文名:

肩关节活动度测量

指标类型:

次要指标

Outcome:

Preoperative shoulder joint range of motion measurement

Type:

Secondary indicator

测量时间点:

术前1h,术后1h,术后6h,次日晨九点

测量方法:

Measure time point of outcome:

1 hour before surgery, 1 hour after surgery, 6 hours after surgery, and 9 o'clock in the morning the next day

Measure method:

指标中文名:

肱二头肌肌力测定:MMT(徒手肌力测试)

指标类型:

次要指标

Outcome:

Biceps Muscle Strength Assessment: MMT (Manual Muscle Testing)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患侧握力测试(Jamar握力计)

指标类型:

次要指标

Outcome:

ipsilateral grip strength test (Jamar dynamometer)

Type:

Secondary indicator

测量时间点:

术后1h,术后6h,次日九点

测量方法:

Measure time point of outcome:

1 hour after surgery, 6 hours after surgery, and 9 o'clock the next day

Measure method:

指标中文名:

术后阿片类药物剂量

指标类型:

次要指标

Outcome:

Postoperative opioid dosage

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后补救镇痛药物剂量

指标类型:

次要指标

Outcome:

Postoperative rescue analgesic dosage

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院时间

指标类型:

次要指标

Outcome:

Hospitalization period

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肱二头肌氧合与血流动力学参数(采用TRAIN.RED FYER近红外光谱仪测定):肱二头肌肌肉氧饱和度(scle Oxygen Saturation, SmO2)

指标类型:

次要指标

Outcome:

Biceps brachii oxygenation and hemodynamic parameters (measured using the TRAIN.RED FYER near-infrared spectroscopy device): Biceps brachii muscle oxygen saturation (smO2)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后不良事件发生率(神经阻滞相关和非神经阻滞相关)

指标类型:

次要指标

Outcome:

Postoperative adverse event incidence (nerve block-related and non-nerve block-related)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者的动态疼痛

指标类型:

次要指标

Outcome:

dynamic pain of the patient

Type:

Secondary indicator

测量时间点:

术前1h,术后1h,术后6h,次日9点,术后24h,术后第二日晨九点

测量方法:

Measure time point of outcome:

1 hour before surgery, 1 hour after surgery, 6 hours after surgery, 9 o'clock the next day, 24 hours after surgery, and 9 o'clock in the morning of the second day after surgery

Measure method:

指标中文名:

氧合血红蛋白浓度(Hb)

指标类型:

次要指标

Outcome:

oxygenated hemoglobin concentration (Hb)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脱氧血红蛋白浓度(HHb)

指标类型:

次要指标

Outcome:

deoxygenated hemoglobin concentration (HHb)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

总血红蛋白浓度(tHb)

指标类型:

次要指标

Outcome:

total hemoglobin concentration (tHb)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白差值(HbDiff, O2Hb – HHb)

指标类型:

次要指标

Outcome:

hemoglobin difference (HbDiff, O2Hb – HHb)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肘关节活动度测量

指标类型:

次要指标

Outcome:

Measurement of elbow joint range of motion

Type:

Secondary indicator

测量时间点:

术前1h,术后1h,术后6h,次日晨九点

测量方法:

Measure time point of outcome:

1 hour before surgery, 1 hour after surgery, 6 hours after surgery, and 9 o'clock in the morning the next day

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究人员采用简单随机化的方法根据随机化数字以1:1的比例将每个参与者随机分配到干预组或对照组。一位不参与数据收集的独立研究助理 使用 Research Randomizer 网站 (https://www.randomizer.org/)生成了一组随机化数字(从 1 到 55)。

Randomization Procedure (please state who generates the random number sequence and by what method):

Researchers used a simple randomization method to randomly assign each participant to either the intervention group or the control group in a 1:1 ratio based on randomization numbers. An independent research assistant, who did not participate in data collection, generated a set of randomization numbers (from 1 to 55) using the Research Randomizer website (https://www.randomizer.org/).

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

结局随访评估员设盲

Blinding:

Outcome follow-up evaluator blinded

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

未说明

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Resman, http://www.medresman.org.cn/loginok.aspx。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Resman, http://www.medresman.org.cn/loginok.aspx.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-05-28 17:57:29